Skip to content
Thursday, November 12, 2026
Aurora Prime

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Deal Because of Data Concerns

Health aid illustration
The offered US funding was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' insistence on confidential data.

This rejection was revealed after a official document from December was disclosed, which showed President Emmerson Mnangagwa believed the agreement was "skewed".

A government spokesman has since stated that the US was requesting health data for research and commercial gain while refused to guarantee the benefits from any future vaccines.

"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has called for further talks to reach a agreement suitable to all parties so the country's vital HIV treatment initiative can proceed.

Wider Context

Zimbabwe's decision follows a similar case in Kenya, where a court suspended a similar deal with the US following concerns were filed about the safety of Kenyans' medical information.

After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).

The agency had overseen assistance for the American government, but Trump stated its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and responsibility.

As per reports, 16 African countries have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.

Details of the Rejected Deal

The money for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this cooperation would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana maintained the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.

"In essence, our country would provide the basic resources for medical research with no assurance that the resulting innovations would be available to our people should a new health crisis emerge."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining systems previously set up via the international health agency.

Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is designed to guarantee that when a nation provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," he added.

"We encourage ongoing dialogue with our US partners on how future co-operation could be designed in a manner that honours the independence and dignity of each country."

Medical Community Response

Medical experts expressed it acknowledged the government's concerns, but recommended that talks must proceed given that much of the country's Aids initiatives were funded by foreign aid.

"If specific concerns exist, including those relating to information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group said.

The halted deal underscores the ongoing debate between receiving vital international aid and safeguarding a country's data in an increasingly interconnected world.

JP
By

Jason Phillips

Elara Vance is a technology journalist and innovation analyst with over a decade of experience covering UK tech startups and digital transformation trends.

Aurora Prime

Type to search articles.